GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » EBITDA per Share

Fisher & Paykel Healthcare (NZSE:FPH) EBITDA per Share : NZ$0.81 (TTM As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare EBITDA per Share?

Fisher & Paykel Healthcare's EBITDA per Share for the six months ended in Sep. 2023 was NZ$0.35. Its EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$0.81.

During the past 12 months, the average EBITDA per Share Growth Rate of Fisher & Paykel Healthcare was 11.30% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -0.30% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 11.80% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Fisher & Paykel Healthcare's EBITDA per Share or its related term are showing as below:

NZSE:FPH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9.8   Med: 11.15   Max: 51.7
Current: -0.3

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Fisher & Paykel Healthcare was 51.70% per year. The lowest was -9.80% per year. And the median was 11.15% per year.

NZSE:FPH's 3-Year EBITDA Growth Rate is ranked worse than
63.41% of 697 companies
in the Medical Devices & Instruments industry
Industry Median: 9.5 vs NZSE:FPH: -0.30

Fisher & Paykel Healthcare's EBITDA for the six months ended in Sep. 2023 was NZ$204 Mil.

During the past 12 months, the average EBITDA Growth Rate of Fisher & Paykel Healthcare was 11.80% per year. During the past 3 years, the average EBITDA Growth Rate was -0.10% per year. During the past 5 years, the average EBITDA Growth Rate was 12.00% per year. During the past 10 years, the average EBITDA Growth Rate was 15.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Fisher & Paykel Healthcare was 53.50% per year. The lowest was -9.60% per year. And the median was 12.10% per year.


Fisher & Paykel Healthcare EBITDA per Share Historical Data

The historical data trend for Fisher & Paykel Healthcare's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare EBITDA per Share Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.75 1.39 1.04 0.75

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.44 0.29 0.46 0.35

Fisher & Paykel Healthcare EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Fisher & Paykel Healthcare's EBITDA per Share for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA per Share(A: Mar. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=433.7/582.093
=0.75

Fisher & Paykel Healthcare's EBITDA per Share for the quarter that ended in Sep. 2023 is calculated as

EBITDA per Share(Q: Sep. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=203.7/583.152
=0.35

EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Fisher & Paykel Healthcare EBITDA per Share Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.

Fisher & Paykel Healthcare (NZSE:FPH) Headlines

From GuruFocus